Deroy & Devereaux Private Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Hold |
410
| – | – | 0.01% | 161 |
|
|
2025
Q1 | $260K | Hold |
410
| – | – | 0.02% | 150 |
|
|
2024
Q4 | $292K | Hold |
410
| – | – | 0.02% | 151 |
|
|
2024
Q3 | $431K | Hold |
410
| – | – | 0.02% | 136 |
|
|
2024
Q2 | $431K | Hold |
410
| – | – | 0.03% | 133 |
|
|
2024
Q1 | $395K | Hold |
410
| – | – | 0.02% | 143 |
|
|
2023
Q4 | $360K | Hold |
410
| – | – | 0.02% | 145 |
|
|
2023
Q3 | $337K | Hold |
410
| – | – | 0.02% | 149 |
|
|
2023
Q2 | $295K | Hold |
410
| – | – | 0.02% | 157 |
|
|
2023
Q1 | $337K | Hold |
410
| – | – | 0.03% | 120 |
|
|
2022
Q4 | $296K | Hold |
410
| – | – | 0.02% | 125 |
|
|
2022
Q3 | $282K | Hold |
410
| – | – | 0.02% | 119 |
|
|
2022
Q2 | $242K | Hold |
410
| – | – | 0.02% | 129 |
|
|
2022
Q1 | $286K | Sell |
410
-5
| -1% | -$3.49K | 0.02% | 138 |
|
|
2021
Q4 | $262K | Buy |
415
+5
| +1% | +$3.16K | 0.02% | 137 |
|
|
2021
Q3 | $248K | Hold |
410
| – | – | 0.02% | 138 |
|
|
2021
Q2 | $229K | Buy |
+410
| New | +$229K | 0.02% | 144 |
|
|
2020
Q4 | – | Sell |
-410
| Closed | -$230K | – | 145 |
|
|
2020
Q3 | $230K | Hold |
410
| – | – | 0.02% | 134 |
|
|
2020
Q2 | $256K | Hold |
410
| – | – | 0.03% | 126 |
|
|
2020
Q1 | $200K | Buy |
+410
| New | +$200K | 0.03% | 129 |
|